Clinical vs genomic risks in breast cancer in 2019: Breast pathologist's appellate review of the controversial results from TAILORx trial

Breast J. 2020 Jul;26(7):1447-1448. doi: 10.1111/tbj.13771. Epub 2020 Feb 20.

Authors

Christina H Wei^{1

2}, Robert West², Daniel Schmolze¹, Sophia K Apple^{1

3}

Affiliations

¹ Department of Pathology, City of Hope National Medical Center, Duarte, CA, USA.
² Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
³ Department of Pathology, University of California at Los Angeles, Los Angeles, CA, USA.

PMID: 32077570
DOI: 10.1111/tbj.13771

No abstract available

MeSH terms

Breast
Breast Neoplasms* / genetics
Female
Genomics
Humans
Pathologists